ROCHE VENTURE FUND
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche. Roche has allocated CHF 500 million to invest in and develop commercially successful innovative life science companies. Roche has been investing in early stage companies as part of collaborations since the early-1990s and independent of collaborations since 2002. All equity investments made by Roche in biotech and diagnostics companies (including collaboration investments) are negotiated a... nd managed by the Roche Venture Fund. In the past 20 years, the Roche Venture Fund has invested in over 60 companies globally. Currently, Roche Venture Fund has a portfolio of around 30 companies located in 10 countries across Europe, North America and the Pacific Region. The fund is an evergreen fund with CHF 500 million available of which approximately 40% is currently invested. The Roche Venture Fund is a committed long-term stable investor with sufficient money reserved in their fund for follow-on financing rounds. As part of a multinational healthcare company, the Roche Venture Fund has access to considerable expertise both internally and externally. We co-invest with leading venture funds, including other corporate venture funds, on a regular basis.
ROCHE VENTURE FUND
Industry:
Biotechnology Health Care Venture Capital
Founded:
2002-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Mobile Non Scaleable Content Facebook Sharer SEO_H2 SEO_H1 Magnolia CMS
Similar Organizations
ABB Technology Ventures
ABB Technology Ventures (ATV) is the strategic venture capital unit of ABB (NYSE: ABB).
Aisling Capital
Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by
ArchiMed
ArchiMed is a French private equity fund focused on the healthcare industry.
HEC Ventures
HEC Ventures is the VC Fund of the HEC Paris community managed by Idinvest Partners.
iNetworks
iNetworks provides capital and strategic management to companies and entrepreneurs.
Innoven Partners
Innoven Partenaires is a leading European venture capital firm, founded in 1998, managed by an international and experienced team with
Lemhi Ventures
Lemhi Ventures is a health care services fund formed by a team of experienced innovators, entrepreneurs, and executives.
ORI Capital
ORI Fund is a VC fund that focuses on investing in innovative companies with disruptive technologies in the healthcare industry globally.
Pittsburgh Life Sciences Greenhouse
The Pittsburgh Life Sciences Greenhouse (PLSG) provides capital investments and customized company formation and business growth services
RMM
RMM is Rudi M. Mariรซn's investment vehicle and focuses on biotechnology
Sanofi Ventures
Sanofi Ventures operates as the corporate venture capital arm of Sanofi.
Sphera Funds Management
Sphera Funds Management is an Israeli based fund manager, established in December 2003. The Fund is specializing in long-short equity
Syncona Partners LLP
Syncona Partners LLP is a healthcare company focused on investing in and building global leaders in life science.
The Vertical Group
The Vertical Group is a New Jersey-based venture capital firm focused on the fields of medical technology and biotechnology.
Think.Health
Think.Health invests as a boutique risk-taker in healthcare ventures.
Tullis Health Investors
Tullis Health Investors is a private equity group that invests primarily in the healthcare sector.
Current Employees Featured
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-02-15 | NMD Pharma | Roche Venture Fund investment in Venture Round - NMD Pharma | 35 M EUR |
2021-12-30 | Good Therapeutics | Roche Venture Fund investment in Series B - Good Therapeutics | 8 M USD |
2021-12-07 | Freenome | Roche Venture Fund investment in Series D - Freenome | 300 M USD |
2021-11-05 | GlycoEra | Roche Venture Fund investment in Series A - GlycoEra | 45 M CHF |
2021-09-27 | Jasper Therapeutics | Roche Venture Fund investment in Post-IPO Equity - Jasper Therapeutics | 100 M USD |
2021-05-17 | Soteria Biotherapeutics | Roche Venture Fund investment in Series A - Soteria Biotherapeutics | 42 M USD |
2021-04-27 | Arch Oncology | Roche Venture Fund investment in Series C - Arch Oncology | 105 M USD |
2021-03-31 | Entrada Therapeutics | Roche Venture Fund investment in Series B - Entrada Therapeutics | 116 M USD |
2021-01-28 | Enthera | Roche Venture Fund investment in Series A - Enthera | 7 M EUR |
2020-12-07 | Enliven Therapeutics | Roche Venture Fund investment in Series A - Enliven Therapeutics | 55 M USD |